The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
Open accessAbstract
SUMMARY Nonalcoholic fatty liver disease is strongly associated with hepatic insulin resistance (HIR); however, the key lipid species and molecular mechanisms linking these conditions are widely debated. We developed a subcellular fractionation method to quantify diacylglycerol (DAG) stereoisomers and ceramides in the endoplasmic reticulum (ER), mitochondria, plasma membrane (PM), lipid droplets and cytosol. Acute knockdown (KD) of diacylglycerol acyltransferase-2 in liver induced HIR in rats. This was due to PM sn-1,2-DAG accumulation, which promoted PKCε activation, and insulin receptor kinase (IRK)-T1160 phosphorylation resulting in decreased IRK-T1162 phosphorylation. Liver PM sn-1,2-DAG content and IRK-T1160 phosphorylation were also higher in humans with HIR. In rats, liver-specific PKCε KD ameliorated high-fat diet-induced HIR by lowering IRK-T1160 phosphorylation, while liver-specific overexpression of constitutively active PKCε-induced HIR by promoting IRK-T1160 phosphorylation. These data identify PM sn-1,2-DAGs as the key pool of lipids that activate PKCε and that hepatic PKCε is both necessary and sufficient in mediating HIR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 1×
“Instead, among all the lipid species associated with NAFLD, DAGs and ceramides are the leading candidates thought to be involved (Chavez and Summers, 2012; Kusminski and Scherer, 2019; Petersen and Shulman, 2017; Samuel and Shulman, 2016).”
BackgroundSelf-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 2×
“Multiple studies have suggested the involvement of PKCε in mediating lipid-induced HIR (Kumashiro et al., 2011; Raddatz et al., 2011; Samuel et al., 2004; Samuel et al., 2007), though many of the interventions used in these studies affected PKCε globally or in multiple tissues.”
BackgroundSelf-citationNonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745 · cited 1×
“DAGs, the penultimate intermediate in triglyceride synthesis, have been shown to be highly associated with hepatic steatosis and HIR in both rodents and humans (Abulizi et al., 2017; Kumashiro et al., 2011; Luukkonen et al., 2016; Magkos et al., 2012; Perry et al., 2015b; Samuel and Shulman, 2018; Ter Horst et al., 20…”
BackgroundSelf-citationPerry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719
Self-citationDissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
Monetti, M., Levin, M. C., Watt, M. J., Sajan, M. P., Marmor, S., Hubbard, B. K., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, R. V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.005 · Cited by 511
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 6×
“Consistent with our prior study (Samuel et al., 2007) Brandon et al. found that WAT PKCε has a role in the regulation of glucose metabolism.”
BackgroundResultInfluentialSelf-citationStone, S. J., Levin, M. C., Zhou, P., Han, J., Walther, T. C., & Farese, R. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805768200 · Cited by 390 · cited 1×
“Since DGAT2 has been shown to be an ER-resident protein (McFie et al., 2011; Stone et al., 2009), the accumulation of sn-1,2-DAGs in the ER following the acute hepatic DGAT2 KD is likely a direct result of transient substrate backup, while the extra DAGs are rapidly shuttled to other membrane compartments such as the…”
BackgroundChoi, C. S., Savage, D. B., Kulkarni, A., Yu, X. X., Liu, Z.-X., Morino, K., Kim, S., Distefano, A., Samuel, V. T., Neschen, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704213200 · Cited by 383
Self-citationRoles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Self-citationHepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2744 · Cited by 335
Self-citationControlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L., & Shulman, G. I. (2015) · Science · doi:10.1126/science.aaa0672 · Cited by 283
Caro, J. F., Ittoop, O., Pories, W. J., Meelheim, D., Flickinger, E. G., Thomas, F., Jenquin, M., Silverman, J. F., Khazanie, P. G., & Sinha, M. K. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112558 · Cited by 215
Camporez, J. P., Lyu, K., Goldberg, E. L., Zhang, D., Cline, G. W., Jurczak, M. J., Dixit, V. D., Petersen, K. F., & Shulman, G. I. (2019) · The Journal of Physiology · doi:10.1113/jp277270 · Cited by 71
Self-citationAbulizi, A., Perry, R. J., Camporez, J. P. G., Jurczak, M. J., Petersen, K. F., Aspichueta, P., & Shulman, G. I. (2017) · The FASEB Journal · doi:10.1096/fj.201700001r · Cited by 41 · cited 2×
“Finally, while it is possible that species differences might also explain the different observations, we do not think this is likely given that we and others have established a strong relationship between hepatic DAG content, PKCε translocation and HIR in mice (Abulizi et al., 2017; Camporez et al., 2019; Tillander et…”
BackgroundSelf-citation
Research works printed but not linked: 29
- Bogan, 2001, Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations, Mol. Cell. Biol., 21, 4785, 10.1128/MCB.21.14.4785-4806.2001 · DOI
- Boni, 1985, The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols, J. Biol. Chem., 260, 10819, 10.1016/S0021-9258(19)85156-6 · DOI · Paper page
- Brandon, 2019, Protein kinase C epsilon deletion in adipose tissue, but not in liver, improves glucose tolerance, Cell Metab., 29, 183, 10.1016/j.cmet.2018.09.013 · DOI
- Brown, 2010, CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance, J. Lipid Res., 51, 3306, 10.1194/jlr.M010256 · DOI
- Cantley, 2013, CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance, Proc. Natl. Acad. Sci. USA, 110, 1869, 10.1073/pnas.1219456110 · DOI · Paper page
- Castle, 2003, Purification of organelles from mammalian cells, Curr. Protoc. Protein Sci., 37, 4.2.1
- Chavez, 2012, A ceramide-centric view of insulin resistance, Cell Metab., 15, 585, 10.1016/j.cmet.2012.04.002 · DOI · Paper page
- Eichmann, 2012, Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases, J. Biol. Chem., 287, 41446, 10.1074/jbc.M112.400416 · DOI · Paper page
- Farese, 2012, The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance, Cell Metab., 15, 570, 10.1016/j.cmet.2012.03.004 · DOI · Paper page
- Gassaway, 2018, PKCepsilon contributes to lipid-induced insulin resistance through cross talk with p70s6K and through previously unknown regulators of insulin signaling, Proc. Natl. Acad. Sci. USA, 115, E8996, 10.1073/pnas.1804379115 · DOI
- Haemmerle, 2002, Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis, J. Biol. Chem., 277, 4806, 10.1074/jbc.M110355200 · DOI · Paper page
- Kumashiro, 2011, Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease, Proc. Natl. Acad. Sci. USA, 108, 16381, 10.1073/pnas.1113359108 · DOI · Paper page
- Kusminski, 2019, Lowering ceramides to overcome diabetes, Science, 365, 319, 10.1126/science.aax6594 · DOI
- Lightwood, 2006, Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells, J. Immunol. Methods, 316, 133, 10.1016/j.jim.2006.08.010 · DOI
- Luukkonen, 2016, Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease, J. Hepatol., 64, 1167, 10.1016/j.jhep.2016.01.002 · DOI · Paper page
- Magkos, 2012, Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects, Gastroenterology, 142, 1444, 10.1053/j.gastro.2012.03.003 · DOI · Paper page
- McFie, 2011, Murine diacylglycerol acyltransferase-2 (DGAT2) can catalyze triacylglycerol synthesis and promote lipid droplet formation independent of its localization to the endoplasmic reticulum, J. Biol. Chem., 286, 28235, 10.1074/jbc.M111.256008 · DOI
- Minehira, 2008, Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice, J. Lipid Res., 49, 2038, 10.1194/jlr.M800248-JLR200 · DOI · Paper page
- Nomura, 1986, Stereospecificity of diacylglycerol for stimulus-response coupling in platelets, Biochem. Biophys. Res. Commun., 140, 1143, 10.1016/0006-291X(86)90754-0 · doi:10.1016/0006-291x(86)90754-0
- Nozaki, 2020, Metabolic control analysis of hepatic glycogen synthesis in vivo, Proc. Natl. Acad. Sci. USA, 117, 8166, 10.1073/pnas.1921694117 · DOI
- Osuga, 2000, Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity, Proc. Natl. Acad. Sci. USA, 97, 787, 10.1073/pnas.97.2.787 · DOI · Paper page
- Perry, 2018, Mechanisms by which a very-low-calorie diet reverses hyperglycemia in a rat model of type 2 diabetes, Cell Metab., 27, 210, 10.1016/j.cmet.2017.10.004 · DOI
- Petersen, 2016, Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance, J. Clin. Invest., 126, 4361, 10.1172/JCI86013 · DOI · Paper page
- Prakash, 2014, Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice, Nucleic Acids Res., 42, 8796, 10.1093/nar/gku531 · DOI · Paper page
- Raddatz, 2011, Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice, Diabetologia, 54, 1447, 10.1007/s00125-011-2073-0 · DOI
- Rando, 1984, The stereospecific activation of protein kinase C, Biochem. Biophys. Res. Commun., 122, 818, 10.1016/S0006-291X(84)80107-2 · DOI
- Takeishi, 2000, Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy, Circ. Res., 86, 1218, 10.1161/01.RES.86.12.1218 · DOI · Paper page
- Ter Horst, 2017, Hepatic diacylglycerol-associated protein kinase cepsilon translocation links hepatic steatosis to hepatic insulin resistance in humans, Cell Rep., 19, 1997, 10.1016/j.celrep.2017.05.035 · DOI · Paper page
- Tillander, 2019, Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis, J. Biol. Chem., 294, 2009, 10.1074/jbc.RA118.005184 · DOI
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“These data identify plasma membrane sn-1,2 DAGs as the key cellular compartment and lipid species that activate PKCε and establish that hepatic PKCε is necessary and sufficient for mediating hepatic insulin resistance (Lyu et al., 2020).”
BackgroundSelf-citationThe aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Metadata
- Authors
- Lyu, K., Zhang, Y., Zhang, D., Kahn, M., ter Horst, K. W., Rodrigues, M. R. S., Gaspar, R. C., Hirabara, S. M., Luukkonen, P. K., Lee, S., Bhanot, S., Rinehart, J., Blume, N., Rasch, M. G., Serlie, M. J., Bogan, J. S., Cline, G. W., Samuel, V. T., & Shulman, G. I.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 32
- Issue
- 4
- Pages
- 654-664.e5
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3081770539
- Cited by
- 170
- References
- 16
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- Funders
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.